entertainment -WSS

entertainment

author：fashion 2025-10-04 04:00:08 - browse：721

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cue Health's Covid

WSS

Medical bills so high, Medicare adding extra digits to claim forms

H5N1 bird flu virus started spreading in cows in Texas in December

What will save rural psychiatry services? Higher Medicaid payments

Lab trade group sues FDA to halt regulation of lab

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Getting Alzheimer's drug Leqembi to patients can be a challenge

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

In Memoriam: Notable people who died in 2023

Orangutan used medicinal plant to treat wound, first time ever seen

How to save PrEP access — and even expand it

Cue Health's Covid

Activists slam private health insurers over coverage restrictions

Focused ultrasound for uterine fibroids: an uphill battle

The cancer drug shortage isn’t new — and neither are the solutions

Cancer researcher Catriona Jamieson is sending tumors into space

Alkermes shareholders re

Addiction doctors spar with methadone clinics over legislation

explore

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Medical bills so high, Medicare adding extra digits to claim forms

Element Biosciences CEO lays out genome sequencing strategy

Akili, maker of video game for ADHD, to be acquired for 34 million

Latest bird flu infection made farmworker sicker than earlier cases

entertainment

focus

Wikipedia

explore